Last 12 months
Inside the activity.
0 purchase rows · 93 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 6 |
| Dec 2025 | 0 | 16 |
| Jan 2026 | 0 | 2 |
| Feb 2026 | 0 | 49 |
| Mar 2026 | 0 | 5 |
| Apr 2026 | 0 | 1 |
| May 2026 | 0 | 6 |
| Jun 2026 | 0 | 5 |
| Jul 2026 | 0 | 3 |
| Aug 2026 | 0 | 0 |
| Sep 2026 | 0 | 0 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| February 06, 2020 Filed Feb 7, 2020 21:17 UTC |
Parini MichaelEVP, CL&AO
|
SaleCommon Stock | 300 | $240.79 | $72,237.00 |
DisclosureSEC source: 0001209191-20-007505 · doc4.xml · nonDerivative · entry 8 Parini Michael · CIK 0001661567 · EVP, CL&AO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 68,400 F4 · kind: Transaction made pursuant to Mr. Parini's company-approved trading plan under Rule 10b5-1. F6 · price: Mr. Parini undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price. F8 · price: Open market sales reported on this line occurred at a weighted average price of $240.79 (range $240.51 to $241.05). Read SEC document |
| February 06, 2020 Filed Feb 7, 2020 21:17 UTC |
Parini MichaelEVP, CL&AO
|
SaleCommon Stock | 585 | $239.58 | $140,154.30 |
DisclosureSEC source: 0001209191-20-007505 · doc4.xml · nonDerivative · entry 7 Parini Michael · CIK 0001661567 · EVP, CL&AO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 68,700 F4 · kind: Transaction made pursuant to Mr. Parini's company-approved trading plan under Rule 10b5-1. F6 · price: Mr. Parini undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price. F7 · price: Open market sales reported on this line occurred at a weighted average price of $239.58 (range $239.17 to $240.11). Read SEC document |
| February 06, 2020 Filed Feb 7, 2020 21:17 UTC |
Parini MichaelEVP, CL&AO
|
SaleCommon Stock | 1,487 | $238.77 | $355,050.99 |
DisclosureSEC source: 0001209191-20-007505 · doc4.xml · nonDerivative · entry 6 Parini Michael · CIK 0001661567 · EVP, CL&AO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 69,285 F4 · kind: Transaction made pursuant to Mr. Parini's company-approved trading plan under Rule 10b5-1. F5 · price: Open market sales reported on this line occurred at a weighted average price of $238.77 (range $238.15 to $239.11). F6 · price: Mr. Parini undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price. Read SEC document |
| February 06, 2020 Filed Feb 7, 2020 21:17 UTC |
Parini MichaelEVP, CL&AO
|
Exercise / conversionCommon Stock | 1,223 | $155.57 | $190,262.11 |
DisclosureSEC source: 0001209191-20-007505 · doc4.xml · nonDerivative · entry 5 Parini Michael · CIK 0001661567 · EVP, CL&AO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 70,772 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 06, 2020 Filed Feb 7, 2020 21:17 UTC |
Parini MichaelEVP, CL&AO
|
Exercise / conversionCommon Stock | 1,303 | $187.53 | $244,351.59 |
DisclosureSEC source: 0001209191-20-007505 · doc4.xml · nonDerivative · entry 4 Parini Michael · CIK 0001661567 · EVP, CL&AO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 69,549 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 06, 2020 Filed Feb 7, 2020 21:27 UTC |
Silva Paul MSVP & Controller
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 466 | $0.00 Strike: $187.53 | $0.00 |
DisclosureSEC source: 0001209191-20-007523 · doc4.xml · derivative · entry 9 Silva Paul M · CIK 0001446372 · SVP & Controller 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,587 Underlying: Common Stock · 466 shares Expires 2029-02-05 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F8 · derivative.exercise_date: The option vests in 16 quarterly installments from 02/06/2019. Read SEC document |
| February 06, 2020 Filed Feb 7, 2020 21:27 UTC |
Silva Paul MSVP & Controller
|
SaleCommon Stock | 31 | $242.47 | $7,516.57 |
DisclosureSEC source: 0001209191-20-007523 · doc4.xml · nonDerivative · entry 7 Silva Paul M · CIK 0001446372 · SVP & Controller 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 30,223 F4 · kind: Transaction made pursuant to Mr. Silva's company approved trading plan under Rule 10b5-1. Read SEC document |
| February 06, 2020 Filed Feb 7, 2020 21:27 UTC |
Silva Paul MSVP & Controller
|
SaleCommon Stock | 92 | $240.46 | $22,122.32 |
DisclosureSEC source: 0001209191-20-007523 · doc4.xml · nonDerivative · entry 6 Silva Paul M · CIK 0001446372 · SVP & Controller 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 30,254 F4 · kind: Transaction made pursuant to Mr. Silva's company approved trading plan under Rule 10b5-1. F6 · price: Mr. Silva undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price. F7 · price: Open market sales reported on this line occurred at a weighted average price of $240.46 (range $240.11 to $240.84). Read SEC document |
| February 06, 2020 Filed Feb 7, 2020 21:27 UTC |
Silva Paul MSVP & Controller
|
SaleCommon Stock | 343 | $238.73 | $81,884.39 |
DisclosureSEC source: 0001209191-20-007523 · doc4.xml · nonDerivative · entry 5 Silva Paul M · CIK 0001446372 · SVP & Controller 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 30,346 F4 · kind: Transaction made pursuant to Mr. Silva's company approved trading plan under Rule 10b5-1. F5 · price: Open market sales reported on this line occurred at a weighted average price of $238.73 (range $238.15 to $239.14). F6 · price: Mr. Silva undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price. Read SEC document |
| February 06, 2020 Filed Feb 7, 2020 21:27 UTC |
Silva Paul MSVP & Controller
|
Exercise / conversionCommon Stock | 466 | $187.53 | $87,388.98 |
DisclosureSEC source: 0001209191-20-007523 · doc4.xml · nonDerivative · entry 4 Silva Paul M · CIK 0001446372 · SVP & Controller 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 30,689 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 06, 2020 Filed Feb 7, 2020 21:28 UTC |
Tatsis OuraniaSVP, CRO
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 408 | $0.00 Strike: $155.57 | $0.00 |
DisclosureSEC source: 0001209191-20-007525 · doc4.xml · derivative · entry 10 Tatsis Ourania · CIK 0001789815 · SVP, CRO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,261 Underlying: Common Stock · 408 shares Expires 2028-02-05 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F9 · derivative.exercise_date: The option vests in 16 quarterly installments from 02/06/2018. Read SEC document |
| February 06, 2020 Filed Feb 7, 2020 21:28 UTC |
Tatsis OuraniaSVP, CRO
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 559 | $0.00 Strike: $187.53 | $0.00 |
DisclosureSEC source: 0001209191-20-007525 · doc4.xml · derivative · entry 9 Tatsis Ourania · CIK 0001789815 · SVP, CRO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,704 Underlying: Common Stock · 559 shares Expires 2029-02-05 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F8 · derivative.exercise_date: The option vests in 16 quarterly installments from 02/06/2019. Read SEC document |
| February 06, 2020 Filed Feb 7, 2020 21:28 UTC |
Tatsis OuraniaSVP, CRO
|
SaleCommon Stock | 66 | $242.47 | $16,003.02 |
DisclosureSEC source: 0001209191-20-007525 · doc4.xml · nonDerivative · entry 8 Tatsis Ourania · CIK 0001789815 · SVP, CRO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 16,946 F3 · kind: Transaction made pursuant to Ms. Tatsis' company-approved trading plan under Rule 10b5-1. Read SEC document |
| February 06, 2020 Filed Feb 7, 2020 21:28 UTC |
Tatsis OuraniaSVP, CRO
|
SaleCommon Stock | 90 | $240.70 | $21,663.00 |
DisclosureSEC source: 0001209191-20-007525 · doc4.xml · nonDerivative · entry 7 Tatsis Ourania · CIK 0001789815 · SVP, CRO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 17,012 F3 · kind: Transaction made pursuant to Ms. Tatsis' company-approved trading plan under Rule 10b5-1. F5 · price: Ms. Tatsis undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price. F7 · price: Open market sales reported on this line occurred at a weighted average price of $240.70 (range $240.47 to $241.04). Read SEC document |
| February 06, 2020 Filed Feb 7, 2020 21:28 UTC |
Tatsis OuraniaSVP, CRO
|
SaleCommon Stock | 240 | $239.68 | $57,523.20 |
DisclosureSEC source: 0001209191-20-007525 · doc4.xml · nonDerivative · entry 6 Tatsis Ourania · CIK 0001789815 · SVP, CRO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 17,102 F3 · kind: Transaction made pursuant to Ms. Tatsis' company-approved trading plan under Rule 10b5-1. F5 · price: Ms. Tatsis undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price. F6 · price: Open market sales reported on this line occurred at a weighted average price of $239.68 (range $239.25 to $240.13). Read SEC document |
| February 06, 2020 Filed Feb 7, 2020 21:28 UTC |
Tatsis OuraniaSVP, CRO
|
SaleCommon Stock | 571 | $238.77 | $136,337.67 |
DisclosureSEC source: 0001209191-20-007525 · doc4.xml · nonDerivative · entry 5 Tatsis Ourania · CIK 0001789815 · SVP, CRO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 17,342 F3 · kind: Transaction made pursuant to Ms. Tatsis' company-approved trading plan under Rule 10b5-1. F4 · price: Open market sales reported on this line occurred at a weighted average price of $238.77 (range $238.20 to $239.14). F5 · price: Ms. Tatsis undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price. Read SEC document |
| February 06, 2020 Filed Feb 7, 2020 21:28 UTC |
Tatsis OuraniaSVP, CRO
|
Exercise / conversionCommon Stock | 408 | $155.57 | $63,472.56 |
DisclosureSEC source: 0001209191-20-007525 · doc4.xml · nonDerivative · entry 4 Tatsis Ourania · CIK 0001789815 · SVP, CRO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 17,913 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 06, 2020 Filed Feb 7, 2020 21:28 UTC |
Tatsis OuraniaSVP, CRO
|
Exercise / conversionCommon Stock | 559 | $187.53 | $104,829.27 |
DisclosureSEC source: 0001209191-20-007525 · doc4.xml · nonDerivative · entry 3 Tatsis Ourania · CIK 0001789815 · SVP, CRO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 17,505 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 06, 2020 Filed Feb 10, 2020 21:14 UTC |
Lee YuchunDirector
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 2,000 | $0.00 Strike: $57.27 | $0.00 |
DisclosureSEC source: 0001209191-20-007871 · doc4.xml · derivative · entry 6 Lee Yuchun · CIK 0001334365 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 16,306 Underlying: Common Stock · 2,000 shares Expires 2022-09-13 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F6 · derivative.exercise_date: Fully vested. Read SEC document |
| February 06, 2020 Filed Feb 10, 2020 21:14 UTC |
Lee YuchunDirector
|
SaleCommon Stock | 100 | $244.08 | $24,408.00 |
DisclosureSEC source: 0001209191-20-007871 · doc4.xml · nonDerivative · entry 5 Lee Yuchun · CIK 0001334365 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,875 F1 · kind: Transaction made pursuant to Mr. Lee's company approved trading plan under Rule 10b5-1. Read SEC document |
| February 06, 2020 Filed Feb 10, 2020 21:14 UTC |
Lee YuchunDirector
|
SaleCommon Stock | 429 | $240.65 | $103,238.85 |
DisclosureSEC source: 0001209191-20-007871 · doc4.xml · nonDerivative · entry 4 Lee Yuchun · CIK 0001334365 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,975 F1 · kind: Transaction made pursuant to Mr. Lee's company approved trading plan under Rule 10b5-1. F3 · price: Mr. Lee undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price. F5 · price: Open market sales reported on this line occurred at a weighted average price of $240.65 (range $240.39 to $241.36). Read SEC document |
| February 06, 2020 Filed Feb 10, 2020 21:14 UTC |
Lee YuchunDirector
|
SaleCommon Stock | 400 | $239.28 | $95,712.00 |
DisclosureSEC source: 0001209191-20-007871 · doc4.xml · nonDerivative · entry 3 Lee Yuchun · CIK 0001334365 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,404 F1 · kind: Transaction made pursuant to Mr. Lee's company approved trading plan under Rule 10b5-1. F3 · price: Mr. Lee undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price. F4 · price: Open market sales reported on this line occurred at a weighted average price of $239.28 (range $239.20 to $239.45). Read SEC document |
| February 06, 2020 Filed Feb 10, 2020 21:14 UTC |
Lee YuchunDirector
|
SaleCommon Stock | 1,071 | $238.71 | $255,658.41 |
DisclosureSEC source: 0001209191-20-007871 · doc4.xml · nonDerivative · entry 2 Lee Yuchun · CIK 0001334365 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,804 F1 · kind: Transaction made pursuant to Mr. Lee's company approved trading plan under Rule 10b5-1. F2 · price: Open market sales reported on this line occurred at a weighted average price of $238.71 (range $238.15 to $239.13). F3 · price: Mr. Lee undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price. Read SEC document |
| February 06, 2020 Filed Feb 10, 2020 21:14 UTC |
Lee YuchunDirector
|
Exercise / conversionCommon Stock | 2,000 | $57.27 | $114,540.00 |
DisclosureSEC source: 0001209191-20-007871 · doc4.xml · nonDerivative · entry 1 Lee Yuchun · CIK 0001334365 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,875 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 05, 2020 Filed Feb 6, 2020 21:06 UTC |
Lee YuchunDirector
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 2,000 | $0.00 Strike: $57.27 | $0.00 |
DisclosureSEC source: 0001209191-20-007151 · doc4.xml · derivative · entry 14 Lee Yuchun · CIK 0001334365 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 18,306 Underlying: Common Stock · 2,000 shares Expires 2022-09-13 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F13 · derivative.exercise_date: Fully vested. Read SEC document |
| February 05, 2020 Filed Feb 6, 2020 21:06 UTC |
Lee YuchunDirector
|
SaleCommon Stock | 332 | $243.78 | $80,934.96 |
DisclosureSEC source: 0001209191-20-007151 · doc4.xml · nonDerivative · entry 12 Lee Yuchun · CIK 0001334365 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,875 F1 · kind: Transaction made pursuant to Mr. Lee's company approved trading plan under Rule 10b5-1. F3 · price: Mr. Lee undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price. F12 · price: Open market sales reported on this line occurred at a weighted average price of $243.78 (range $243.63 to $243.95). Read SEC document |
| February 05, 2020 Filed Feb 6, 2020 21:06 UTC |
Lee YuchunDirector
|
SaleCommon Stock | 637 | $243.13 | $154,873.81 |
DisclosureSEC source: 0001209191-20-007151 · doc4.xml · nonDerivative · entry 11 Lee Yuchun · CIK 0001334365 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,207 F1 · kind: Transaction made pursuant to Mr. Lee's company approved trading plan under Rule 10b5-1. F3 · price: Mr. Lee undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price. F11 · price: Open market sales reported on this line occurred at a weighted average price of $243.13 (range $242.56 to $243.52). Read SEC document |
| February 05, 2020 Filed Feb 6, 2020 21:06 UTC |
Lee YuchunDirector
|
SaleCommon Stock | 629 | $242.03 | $152,236.87 |
DisclosureSEC source: 0001209191-20-007151 · doc4.xml · nonDerivative · entry 10 Lee Yuchun · CIK 0001334365 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,844 F1 · kind: Transaction made pursuant to Mr. Lee's company approved trading plan under Rule 10b5-1. F3 · price: Mr. Lee undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price. F10 · price: Open market sales reported on this line occurred at a weighted average price of $242.03 (range $241.53 to $242.52). Read SEC document |
| February 05, 2020 Filed Feb 6, 2020 21:06 UTC |
Lee YuchunDirector
|
SaleCommon Stock | 402 | $240.59 | $96,717.18 |
DisclosureSEC source: 0001209191-20-007151 · doc4.xml · nonDerivative · entry 9 Lee Yuchun · CIK 0001334365 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,473 F1 · kind: Transaction made pursuant to Mr. Lee's company approved trading plan under Rule 10b5-1. F3 · price: Mr. Lee undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price. F9 · price: Open market sales reported on this line occurred at a weighted average price of $240.59 (range $240.37 to $240.70). Read SEC document |
| February 05, 2020 Filed Feb 6, 2020 21:06 UTC |
Lee YuchunDirector
|
Exercise / conversionCommon Stock | 2,000 | $57.27 | $114,540.00 |
DisclosureSEC source: 0001209191-20-007151 · doc4.xml · nonDerivative · entry 8 Lee Yuchun · CIK 0001334365 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,875 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 05, 2020 Filed Feb 7, 2020 21:07 UTC |
ALTSHULER DAVIDEVP, Global Research and CSO
|
GrantCommon Stock | 12,387 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-20-007474 · doc4.xml · nonDerivative · entry 3 ALTSHULER DAVID · CIK 0001550395 · EVP, Global Research and CSO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 70,310 F3 · shares: Restricted stock unit award that vests in installments beginning on 02/10/2021. Read SEC document |
| February 05, 2020 Filed Feb 7, 2020 21:07 UTC |
ALTSHULER DAVIDEVP, Global Research and CSO
|
GrantCommon Stock | 8,166 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-20-007474 · doc4.xml · nonDerivative · entry 2 ALTSHULER DAVID · CIK 0001550395 · EVP, Global Research and CSO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 57,923 F2 · shares: Represents earned performance shares with respect to a performance stock unit award granted on 02/06/2019 that contained performance-vesting requirements. The issuer's management development and compensation committee certified as to the level of performance-goal attainment on 02/05/2020. The earned performance shares will vest in installments beginning on 02/24/2020. Read SEC document |
| February 05, 2020 Filed Feb 7, 2020 21:07 UTC |
ALTSHULER DAVIDEVP, Global Research and CSO
|
GrantCommon Stock | 18,204 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-20-007474 · doc4.xml · nonDerivative · entry 1 ALTSHULER DAVID · CIK 0001550395 · EVP, Global Research and CSO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 49,757 F1 · shares: Represents earned performance shares with respect to a performance stock unit award granted on 02/03/2017 that contained performance-vesting requirements. The issuer's management development and compensation committee certified as to the level of performance-goal attainment on 02/05/2020 and the shares will vest on 02/10/2020. Read SEC document |
| February 05, 2020 Filed Feb 7, 2020 21:08 UTC |
Arbuckle Stuart AEVP, Chief Commercial Officer
|
GrantCommon Stock | 12,387 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-20-007477 · doc4.xml · nonDerivative · entry 3 Arbuckle Stuart A · CIK 0001557290 · EVP, Chief Commercial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 67,563 F3 · shares: Restricted stock unit award that vests in installments beginning on 02/10/2021. Read SEC document |
| February 05, 2020 Filed Feb 7, 2020 21:08 UTC |
Arbuckle Stuart AEVP, Chief Commercial Officer
|
GrantCommon Stock | 9,800 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-20-007477 · doc4.xml · nonDerivative · entry 2 Arbuckle Stuart A · CIK 0001557290 · EVP, Chief Commercial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 55,176 F2 · shares: Represents earned performance shares with respect to a performance stock unit award granted on 02/06/2019 that contained performance-vesting requirements. The issuer's management development and compensation committee certified as to the level of performance-goal attainment on 02/05/2020. The earned performance shares will vest in installments beginning on 02/24/2020. Read SEC document |
| February 05, 2020 Filed Feb 7, 2020 21:08 UTC |
Arbuckle Stuart AEVP, Chief Commercial Officer
|
GrantCommon Stock | 12,136 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-20-007477 · doc4.xml · nonDerivative · entry 1 Arbuckle Stuart A · CIK 0001557290 · EVP, Chief Commercial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 45,376 F1 · shares: Represents earned performance shares with respect to a performance stock unit award granted on 02/03/2017 that contained performance-vesting requirements. The issuer's management development and compensation committee certified as to the level of performance-goal attainment on 02/05/2020 and the shares will vest on 02/10/2020. Read SEC document |
| February 05, 2020 Filed Feb 7, 2020 21:10 UTC |
Bozic CarmenEVP, GMDA
|
GrantCommon Stock | 10,323 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-20-007481 · doc4.xml · nonDerivative · entry 2 Bozic Carmen · CIK 0001790029 · EVP, GMDA 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 14,518 F2 · shares: Restricted stock unit award that vests in installments beginning on 02/10/2021. Read SEC document |
| February 05, 2020 Filed Feb 7, 2020 21:10 UTC |
Bozic CarmenEVP, GMDA
|
GrantCommon Stock | 2,098 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-20-007481 · doc4.xml · nonDerivative · entry 1 Bozic Carmen · CIK 0001790029 · EVP, GMDA 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,195 F1 · shares: Represents earned performance shares with respect to a performance stock unit award granted on 05/20/2019 that contained performance-vesting requirements. The issuer's management development and compensation committee certified as to the level of performance-goal attainment on 02/05/2020. The earned performance shares will vest in installments beginning on 2/24/2020. Read SEC document |
| February 05, 2020 Filed Feb 7, 2020 21:14 UTC |
Kewalramani ReshmaEVP and CMO
|
GrantCommon Stock | 12,387 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-20-007485 · doc4.xml · nonDerivative · entry 2 Kewalramani Reshma · CIK 0001735944 · EVP and CMO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 35,285 F2 · shares: Restricted stock unit award that vests in installments beginning on 02/10/2021. Read SEC document |
| February 05, 2020 Filed Feb 7, 2020 21:14 UTC |
Kewalramani ReshmaEVP and CMO
|
GrantCommon Stock | 9,800 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-20-007485 · doc4.xml · nonDerivative · entry 1 Kewalramani Reshma · CIK 0001735944 · EVP and CMO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 22,898 F1 · shares: Represents earned performance shares with respect to a performance stock unit award granted on 02/06/2019 that contained performance-vesting requirements. The issuer's management development and compensation committee certified as to the level of performance-goal attainment on 02/05/2020. The earned performance shares will vest in installments beginning on 2/24/2020. Read SEC document |
| February 05, 2020 Filed Feb 7, 2020 21:17 UTC |
Parini MichaelEVP, CL&AO
|
GrantCommon Stock | 10,323 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-20-007505 · doc4.xml · nonDerivative · entry 3 Parini Michael · CIK 0001661567 · EVP, CL&AO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 68,246 F3 · shares: Restricted stock unit award that vests in installments beginning on 02/10/2021. Read SEC document |
| February 05, 2020 Filed Feb 7, 2020 21:17 UTC |
Parini MichaelEVP, CL&AO
|
GrantCommon Stock | 8,166 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-20-007505 · doc4.xml · nonDerivative · entry 2 Parini Michael · CIK 0001661567 · EVP, CL&AO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 57,923 F2 · shares: Represents earned performance shares with respect to a performance stock unit award granted on 02/06/2019 that contained performance-vesting requirements. The issuer's management development and compensation committee certified as to the level of performance-goal attainment on 02/05/2020. The earned performance shares will vest in installments beginning on 02/24/2020. Read SEC document |
| February 05, 2020 Filed Feb 7, 2020 21:17 UTC |
Parini MichaelEVP, CL&AO
|
GrantCommon Stock | 18,204 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-20-007505 · doc4.xml · nonDerivative · entry 1 Parini Michael · CIK 0001661567 · EVP, CL&AO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 49,757 F1 · shares: Represents earned performance shares with respect to a performance stock unit award granted on 02/03/2017 that contained performance-vesting requirements. The issuer's management development and compensation committee certified as to the level of performance-goal attainment on 02/05/2020 and the shares will vest on 02/10/2020. Read SEC document |
| February 05, 2020 Filed Feb 7, 2020 21:24 UTC |
Sachdev AmitEVP, Chief Patient Officer
|
GrantCommon Stock | 10,323 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-20-007519 · doc4.xml · nonDerivative · entry 3 Sachdev Amit · CIK 0001406338 · EVP, Chief Patient Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 71,483 F3 · shares: Restricted stock unit award that vests in installments beginning on 02/10/2021. Read SEC document |
| February 05, 2020 Filed Feb 7, 2020 21:24 UTC |
Sachdev AmitEVP, Chief Patient Officer
|
GrantCommon Stock | 9,800 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-20-007519 · doc4.xml · nonDerivative · entry 2 Sachdev Amit · CIK 0001406338 · EVP, Chief Patient Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 61,160 F2 · shares: Represents earned performance shares with respect to a performance stock unit award granted on 02/06/2019 that contained performance-vesting requirements. The issuer's management development and compensation committee certified as to the level of performance-goal attainment on 02/05/2020. The earned performance shares will vest in installments beginning on 2/24/2020. Read SEC document |
| February 05, 2020 Filed Feb 7, 2020 21:24 UTC |
Sachdev AmitEVP, Chief Patient Officer
|
GrantCommon Stock | 15,170 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-20-007519 · doc4.xml · nonDerivative · entry 1 Sachdev Amit · CIK 0001406338 · EVP, Chief Patient Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 51,360 F1 · shares: Represents earned performance shares with respect to a performance stock unit award granted on 02/03/2017 that contained performance-vesting requirements. The issuer's management development and compensation committee certified as to the level of performance-goal attainment on 02/05/2020 and the shares will vest on 02/10/2020. Read SEC document |
| February 05, 2020 Filed Feb 7, 2020 21:27 UTC |
Silva Paul MSVP & Controller
|
GrantCommon Stock | 3,226 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-20-007523 · doc4.xml · nonDerivative · entry 3 Silva Paul M · CIK 0001446372 · SVP & Controller 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 30,223 F3 · shares: Restricted stock unit award that vests in installments beginning on 02/10/2021. Read SEC document |
| February 05, 2020 Filed Feb 7, 2020 21:27 UTC |
Silva Paul MSVP & Controller
|
GrantCommon Stock | 2,918 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-20-007523 · doc4.xml · nonDerivative · entry 2 Silva Paul M · CIK 0001446372 · SVP & Controller 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 26,997 F2 · shares: Represents earned performance shares with respect to a performance stock unit award granted on 02/06/2019 that contained performance-vesting requirements. The issuer's management development and compensation committee certified as to the level of performance-goal attainment on 02/05/2020. The earned performance shares will vest in installments beginning on 02/24/2020. Read SEC document |
| February 05, 2020 Filed Feb 7, 2020 21:27 UTC |
Silva Paul MSVP & Controller
|
GrantCommon Stock | 6,320 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-20-007523 · doc4.xml · nonDerivative · entry 1 Silva Paul M · CIK 0001446372 · SVP & Controller 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 24,079 F1 · shares: Represents earned performance shares with respect to a performance stock unit award granted on 02/03/2017 that contained performance-vesting requirements. The issuer's management development and compensation committee certified as to the level of performance-goal attainment on 02/05/2020 and the shares will vest on 02/10/2020. Read SEC document |
| February 05, 2020 Filed Feb 7, 2020 21:28 UTC |
Tatsis OuraniaSVP, CRO
|
GrantCommon Stock | 6,194 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-20-007525 · doc4.xml · nonDerivative · entry 2 Tatsis Ourania · CIK 0001789815 · SVP, CRO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 16,946 F2 · shares: Restricted stock unit award that vests in installments beginning on 02/10/2021. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.